Susceptibility of penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to newer antimicrobial agents. 1999

M C Rubio, and P Goñi, and Y Vergara, and C Seral, and C García, and P Gómez-Lus, and R Gómez-Lus
Department of Microbiology, University Hospital, Zaragoza, Spain.

Agar dilution minimum inhibitory concentration (MIC) methodology, according to NCCLS guidelines, was used to test the activity of three glycopeptides (LY 333328 [LY], vancomycin [VAN], and teicoplanin [TEI]), four fluoroquinolones (trovafloxacin [TRO], BAY 12-8039 [BAY], ciprofloxacin [CIP], and ofloxacin [OFL]), five macrolide-lincosamide-streptogramin antibiotics (erythromycin [ERY], azithromycin [AZI], miocamycin [MOM], clindamycin CLN], and quinupristin-dalfopristin [SYN] against 126 Streptococcus pneumoniae strains, isolated in Lozano Blesa Hospital of Zaragoza (Spain). MIC50/MIC90 (microg/ml) values for penicillin-susceptible (PS), penicillin-intermediate (PI) and penicillin-resistant (PR) strains show an excellent antipneumococcal activity of LY 333326--a new glycopeptide, for the fluoroquinolones trovafloxacin and moxifloxacin [BAY 12-8039], and for quinupristin/dalfopristin, regardless of the resistance phenotype of the strains.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013296 Streptococcus pneumoniae A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals. Diplococcus pneumoniae,Pneumococcus
D018942 Macrolides A group of often glycosylated macrocyclic compounds formed by chain extension of multiple PROPIONATES cyclized into a large (typically 12, 14, or 16)-membered lactone. Macrolides belong to the POLYKETIDES class of natural products, and many members exhibit ANTIBIOTIC properties. Macrolide
D024841 Fluoroquinolones A group of QUINOLONES with at least one fluorine atom and a piperazinyl group. Fluoroquinolone

Related Publications

M C Rubio, and P Goñi, and Y Vergara, and C Seral, and C García, and P Gómez-Lus, and R Gómez-Lus
May 1987, Diagnostic microbiology and infectious disease,
M C Rubio, and P Goñi, and Y Vergara, and C Seral, and C García, and P Gómez-Lus, and R Gómez-Lus
January 1982, Reviews of infectious diseases,
M C Rubio, and P Goñi, and Y Vergara, and C Seral, and C García, and P Gómez-Lus, and R Gómez-Lus
April 1999, Current infectious disease reports,
M C Rubio, and P Goñi, and Y Vergara, and C Seral, and C García, and P Gómez-Lus, and R Gómez-Lus
December 2001, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
M C Rubio, and P Goñi, and Y Vergara, and C Seral, and C García, and P Gómez-Lus, and R Gómez-Lus
January 1995, Journal of clinical microbiology,
M C Rubio, and P Goñi, and Y Vergara, and C Seral, and C García, and P Gómez-Lus, and R Gómez-Lus
November 1993, The Journal of antimicrobial chemotherapy,
M C Rubio, and P Goñi, and Y Vergara, and C Seral, and C García, and P Gómez-Lus, and R Gómez-Lus
July 1992, The Journal of antimicrobial chemotherapy,
M C Rubio, and P Goñi, and Y Vergara, and C Seral, and C García, and P Gómez-Lus, and R Gómez-Lus
September 1980, Antimicrobial agents and chemotherapy,
M C Rubio, and P Goñi, and Y Vergara, and C Seral, and C García, and P Gómez-Lus, and R Gómez-Lus
July 1997, The Journal of antimicrobial chemotherapy,
M C Rubio, and P Goñi, and Y Vergara, and C Seral, and C García, and P Gómez-Lus, and R Gómez-Lus
April 1989, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!